ID |
Plasmid |
Gene/Insert |
Vector Type |
Publication |
97307 |
AAV_Efs_hSpCas9_NLS_FLAG-SV40 |
humanized S. pyogenes Cas9 |
Mammalian Expression, Mouse Targeting, AAV |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97308 |
AAV_Actb HMEJ donor_U6_sgRNA_EF1a_GFP_polyA |
Actb HMEJ donor |
Mammalian Expression, Mouse Targeting, AAV |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97309 |
AAV_Actb HR donor_U6_sgRNA_EF1a_GFP_polyA |
Actb HR donor |
Mammalian Expression, Mouse Targeting, AAV |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97310 |
AAV_Actb NHEJ donor_U6_sgRNA_EF1a_GFP_polyA |
Actb NHEJ donor |
Mammalian Expression, Mouse Targeting, AAV |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97311 |
AAV_Actb MMEJ donor_U6_sgRNA_EF1a_GFP_polyA |
Actb MMEJ donor |
Mammalian Expression, Mouse Targeting, AAV |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97312 |
Lenti_Actb HMEJ donor_U6_sgRNA_EF1a_GFP_polyA |
Actb HMEJ donor |
Mammalian Expression, Mouse Targeting, Lentiviral |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97313 |
Lenti_Efs_hSpCas9_NLS_FLAG-WPRE |
humanized S. pyogenes Cas9 |
Mammalian Expression, Mouse Targeting, Lentiviral |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97316 |
AAV_Actb NHEJ donor |
Actb NHEJ donor |
Mammalian Expression, Mouse Targeting |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97317 |
AAV_Actb HR donor |
Actb HR donor |
Mammalian Expression, Mouse Targeting |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97318 |
AAV_Actb HMEJ donor |
Actb HMEJ donor |
Mammalian Expression, Mouse Targeting |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97319 |
AAV_Cdx2 HMEJ donor |
Cdx2 HMEJ donor |
Mammalian Expression, Mouse Targeting |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97320 |
AAV_Dbh HMEJ donor |
Dbh HMEJ donor |
Mammalian Expression, Mouse Targeting |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97321 |
AAV_Nanog HMEJ donor |
Nanog HMEJ donor |
Mammalian Expression, Mouse Targeting |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
97322 |
AAV_Sox2 HMEJ donor |
Sox2 HMEJ donor |
Mammalian Expression, Mouse Targeting |
Homology-mediated end joining-based targeted integration using CRISPR/Cas9. Cell Res. 2017 May 19. doi: 10.1038/cr.2017.76. |
107307 |
CAG-LoxpStopLoxp-NLS-dCas9-HA-NLS-NLS-10xGCN4-NLS-P2A-scFv-NLS-P65-HSF1-Flag-T2A-EGFP-WPRE-PolyA |
CAG-LSL-dCas9-10xGCN4-P2A-scFv-P65-HSF1-T2A-EGFP-WPRE-PolyA |
Mammalian Expression |
In vivosimultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat Neurosci. 2018 Jan 15. pii: 10.1038/s41593-017-0060-6. doi: 10.1038/s41593-017-0060-6. |
107310 |
dSV40-NLS-dCas9-HA-NLS-NLS-10xGCN4 |
dSV40-dCas9-10xGCN4 |
Mammalian Expression, Lentiviral |
In vivosimultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat Neurosci. 2018 Jan 15. pii: 10.1038/s41593-017-0060-6. doi: 10.1038/s41593-017-0060-6. |
107311 |
EF1α-scFv-p65-HSF1-T2A-EGFP-WPRE-PolyA |
EF1_-scFv-p65-HSF1-T2A-EGFP-WPRE-PolyA |
Mammalian Expression, Lentiviral |
In vivosimultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat Neurosci. 2018 Jan 15. pii: 10.1038/s41593-017-0060-6. doi: 10.1038/s41593-017-0060-6. |
107312 |
AAV-hSyn-mCherry-P2A-Cre-WPRE |
hSyn-mCherry-P2A-Cre-WPRE |
Mammalian Expression, AAV |
In vivosimultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat Neurosci. 2018 Jan 15. pii: 10.1038/s41593-017-0060-6. doi: 10.1038/s41593-017-0060-6. |
107313 |
AAV-aCamkII-mCherry-P2A-Cre-WPRE-BGH-polyA |
aCamkII-mCherry-P2A-Cre-WPRE-BGH-polyA |
Mammalian Expression, AAV |
In vivosimultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice. Nat Neurosci. 2018 Jan 15. pii: 10.1038/s41593-017-0060-6. doi: 10.1038/s41593-017-0060-6. |
154000 |
AAV-GFAP-NLS-CasRx-NLS-FLAG |
CasRx |
CRISPR |
Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice. Cell. 2020 Apr 30;181(3):590-603.e16. doi: 10.1016/j.cell.2020.03.024. Epub 2020 Apr 8. |
154001 |
AAV-GFAP-NLS-CasRx-NLS-FLAG-U6-DR-SgRNA_Ptbp1-DR |
CasRx |
Mouse Targeting, CRISPR |
Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice. Cell. 2020 Apr 30;181(3):590-603.e16. doi: 10.1016/j.cell.2020.03.024. Epub 2020 Apr 8. |
154002 |
PB-U6-DR-SgRNA-DR-EF1a-mCherry-SV40 |
SgRNA expression system |
CRISPR |
Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver. Protein Cell. 2020 Mar 18. pii: 10.1007/s13238-020-00700-2. doi: 10.1007/s13238-020-00700-2. |
154003 |
AAV-EFS-NLS-CasRx-U6-DR-sgRNA_LacZ-DR |
CasRx |
CRISPR |
Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver. Protein Cell. 2020 Mar 18. pii: 10.1007/s13238-020-00700-2. doi: 10.1007/s13238-020-00700-2. |
154004 |
PB-CAG-CasRX-P2A-EGFP-BGH PolyA |
CasRx |
CRISPR |
Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver. Protein Cell. 2020 Mar 18. pii: 10.1007/s13238-020-00700-2. doi: 10.1007/s13238-020-00700-2. |
154005 |
CMV-YE1-BE3-FNLS-CMV-mCherry |
YE1-BE3-FNLS |
CRISPR |
A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects. Nat Methods. 2020 May 18. pii: 10.1038/s41592-020-0832-x. doi: 10.1038/s41592-020-0832-x. |